Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP96721.RAdVDudn8lm2JPtvfp-9zC1irB0kg97gR7vqq5qKevbEo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP96721.RAdVDudn8lm2JPtvfp-9zC1irB0kg97gR7vqq5qKevbEo130_assertion type Assertion NP96721.RAdVDudn8lm2JPtvfp-9zC1irB0kg97gR7vqq5qKevbEo130_head.
- NP96721.RAdVDudn8lm2JPtvfp-9zC1irB0kg97gR7vqq5qKevbEo130_assertion wasGeneratedBy ECO_0000203 NP96721.RAdVDudn8lm2JPtvfp-9zC1irB0kg97gR7vqq5qKevbEo130_provenance.
- NP96721.RAdVDudn8lm2JPtvfp-9zC1irB0kg97gR7vqq5qKevbEo130_assertion wasDerivedFrom gad-20150221 NP96721.RAdVDudn8lm2JPtvfp-9zC1irB0kg97gR7vqq5qKevbEo130_provenance.
- NP96721.RAdVDudn8lm2JPtvfp-9zC1irB0kg97gR7vqq5qKevbEo130_assertion SIO_000772 19493232 NP96721.RAdVDudn8lm2JPtvfp-9zC1irB0kg97gR7vqq5qKevbEo130_provenance.
- NP96721.RAdVDudn8lm2JPtvfp-9zC1irB0kg97gR7vqq5qKevbEo130_assertion evidence source_evidence_literature NP96721.RAdVDudn8lm2JPtvfp-9zC1irB0kg97gR7vqq5qKevbEo130_provenance.
- NP96721.RAdVDudn8lm2JPtvfp-9zC1irB0kg97gR7vqq5qKevbEo130_assertion description "[Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP96721.RAdVDudn8lm2JPtvfp-9zC1irB0kg97gR7vqq5qKevbEo130_provenance.